Skip to content
Joints & Immunity — TNF inhibitorsATC L04AB04

Adalimumab

Prescription only

Biologic injection for arthritis, IBD and psoriasis.

Starts working
Varies
Half-life
About 2 weeks
In use since
2002
Pregnancy
Use with caution

Overview

Adalimumab blocks TNF, a central driver of inflammation. Self-injected every 1–2 weeks, it treats rheumatoid arthritis, ankylosing spondylitis, Crohn's, ulcerative colitis, psoriasis and hidradenitis. As Humira it was the world's top-selling drug for years; cheaper biosimilars are now widely available.

How it works

Mops up a key inflammation signal.

Adalimumab belongs to the TNF inhibitors. How TNF inhibitors work: mop up TNF, a key inflammation messenger. Infections like TB can reactivate, so people are screened first.

Uses

  • Rheumatoid and psoriatic arthritis
  • Ankylosing spondylitis
  • Crohn's disease and ulcerative colitis
  • Psoriasis
  • Hidradenitis suppurativa
  • Uveitis

Available as: pre-filled pen, pre-filled syringe.

Typical dose

Adults
40 mg under the skin every other week (some conditions start higher or go weekly).

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Injection-site reactions
  • Upper respiratory infections
  • Headache

Serious — get medical help

Uncommon, but need prompt attention

  • Serious infections including TB reactivation
  • Lymphoma (rare)
  • Demyelination
  • Heart failure worsening

Warnings

  • TB and hepatitis B screening first
  • No live vaccines
  • Pause during serious infection

Interactions

  • Other biologics — avoid combining
  • Live vaccines
Check Adalimumab against your own medicines

Pregnancy and breastfeeding

Use with caution

Often continued into pregnancy for IBD; baby's live vaccines may be delayed.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Humira, Hadlima, Hyrimoz, Yuflyma
United Kingdom
Humira, Amgevita, Imraldi, Yuflyma
India
Exemptia, Adfrar
Australia
Humira, Amgevita

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

India launched the world's first adalimumab biosimilar, Exemptia, in 2014.

Common questions

Are biosimilars as good?

Yes — they're tested to show no meaningful difference in effect or safety.

Do I need a prescription for Adalimumab?

Yes — Adalimumab is prescription-only in most countries.

Can I take Adalimumab during pregnancy?

Use with caution. Often continued into pregnancy for IBD; baby's live vaccines may be delayed. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.